The data we have comes from separate trial programs with different designs, different patient populations, and different endpoints
C., Taylor, D
Ristori C et al
As use of this medication is extended and expanded for weight loss and other health advocacy, there is an opportunity to do much more, including product development, packaging, online and in-store merchandising, education, and promotion. Opportunities include: Merchandise dietary and nutritional support items near the pharmacy in drug and grocery, improving the shopping experience for consumers taking GLP-1s Understand that 91% of Millennials, 90% of Gen Z, and 64% of Gen X on GLP-1 medications are interested in packaged foods that support their weight loss goals, and they want messaging called out on the package Meet consumers where they are with product and health information, amplifying digital commerce programming Advance opportunities on retailer apps and websites to support these shoppers Acosta Groups GLP-1 & The Weight Loss Revolution Shopper Insights Study was conducted Feb
Learn More About My Peptide Pal No credit card required
However, this contrasts to findings from earlier infusions of exogenous GIP(1-42), which failed to enhance insulin secretion in individuals with type 2 diabetes (88, 89)
